Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

This week, the highest court in New York, the Court of Appeals handed down a ruling that we all sort of saw coming: the ...

Major insurers will pledge to smooth and speed “prior authorization,” in a new industry initiative.

A small, growing number of employers are putting health insurance decisions entirely in the hands of their workers. Instead ...

Health care exchanges in Maine, Massachusetts, Nevada and Rhode Island shared users’ sensitive health data with companies ...

The FDA is staffed with medical experts who have the capability to evaluate insurance algorithms before they are used to make coverage decisions. The agency already reviews many medical AI tools for ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...

The trustees say the latest findings show the urgency of needed changes to the programs, which have faced dire financial ...

The House-passed One Big Beautiful Bill Act, which runs more than 1,000 pages, would create paperwork requirements that could ...

There are many domestic issues of sufficient magnitude to be honestly labelled crises. President Donald Trump has begun to ...